Convenient synthesis of 1,3-disubstituted-2-thioxo-imidazolidin-4-ones as potential anti-tumor agents
DOI:
https://doi.org/10.7439/ijpc.v5i9.2239Keywords:
Left main coronary artery, aneurysm, coronary artery aneurysm, AngiographyAbstract
1-(Arylidene)amino-2-thioxo-imidazolidine-4-ones ( 3 a,b) have been synthesized via cyclization of 1-(arylidene)amino-3-(chloroacetyl)thiourease ( 2 a,b) in ethanol in presence of fused sodium acetate under heating. Acetylation of compounds ( 3 a,b) with acetic anhydride yielded the corresponding 1-(arylidene)amino-2-thioxo-3-acetylimidazolidin-4-ones ( 4 a, b). Condensation of compounds ( 3 a,b) with aromatic aldehydes in presence of piperidine yielded the corresponding aryl-[1-(arylidine)amino-2-thioxo-4-oxo-imidazolidin-3-yl)carbanols ( 6 a-d). Halogenation of 1-(phenylethylidene)amino-2-thioxoimidazolidin-4-one ( 3 b) with one mole of bromine produced N-bromo- 2- thioxoimidazolidin-4-one ( 9 ), while brominating 1-(benzylidene)amino-2-thioxoimidazolidin-4-one ( 3 a) with two mole of bromine gave the corresponding 3,5-dibromo-2-thioxoimidazolidin-4-one derivative ( 10 ). The characterization of all synthesized compounds were done by elemental analysis and spectral studies. Moreover, the cytotoxic activities of the synthesized compounds were evaluated against human hepatocellular carcinoma cell line (HePG2) using MTT viability test. The results showed that the investigated compounds have a significantly cytotoxic effect.Downloads
Downloads
Published
2015-10-04
Issue
Section
Research Articles
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.
How to Cite
1.
Convenient synthesis of 1,3-disubstituted-2-thioxo-imidazolidin-4-ones as potential anti-tumor agents. Int J of Pharm Chem [Internet]. 2015 Oct. 4 [cited 2025 Jun. 9];5(9):297-30. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/2239